Vonoprazan Fumarate

Vonoprazan Fumarate is a new-generation potassium-competitive acid blocker (P-CAB) used to treat acid-related conditions such as GERD, peptic ulcers, and H. pylori infections. Compared to traditional proton pump inhibitors (PPIs), Vonoprazan Fumarate offers faster onset, stronger and longer-lasting acid suppression, and improved treatment consistency. It is commonly used in oral solid formulations such as tablets or combination therapies for gastrointestinal disorders.